Covered recipient · General Payments record
GINA F ALBERT
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,164.57
- Reported across 79 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $290.28 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $68.52 | 4 |
| ABBVIE INC. | $65.12 | 4 |
| Lilly USA, LLC | $42.83 | 3 |
| Novo Nordisk AS | $32.41 | 2 |
| Lundbeck LLC | $23.05 | 1 |
| SANOFI PASTEUR INC. | $15.53 | 1 |
| GlaxoSmithKline, LLC. | $15.16 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.25 | 1 |
| Exact Sciences Corporation | $13.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.21 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106422044 | CMS |
| ABBVIE INC. | $18.24 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106422046 | CMS |
| ABBVIE INC. | $19.09 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106422048 | CMS |
| ABBVIE INC. | $13.58 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106422050 | CMS |
| Amgen Inc. | $22.98 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115414937 | CMS |
| Amgen Inc. | $14.46 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115414941 | CMS |
| Amgen Inc. | $13.07 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115414929 | CMS |
| Amgen Inc. | $18.01 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115414933 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.25 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118250881 | CMS |
| Exact Sciences Corporation | $13.41 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114454801 | CMS |
| GlaxoSmithKline, LLC. | $15.16 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116544640 | CMS |
| Lilly USA, LLC | $15.13 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135660967 | CMS |
| Lilly USA, LLC | $14.53 | 09/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135660965 | CMS |
| Lilly USA, LLC | $13.17 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135660969 | CMS |
| Lundbeck LLC | $23.05 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145986662 | CMS |
| Novo Nordisk Inc | $16.10 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100304327 | CMS |
| Novo Nordisk Inc | $16.31 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100277994 | CMS |
| SANOFI PASTEUR INC. | $15.53 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128742510 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.